| Trial Identifier: | GM-IMAB-002-01 |
| Sponsor: | Ganymed Pharmaceuticals GmbH |
| Start Date: | February 2014 |
| Primary Completion Date: | October 2015 |
| Condition: | Ovarian Cancer |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| Country | Location |
|---|---|
| Belgium | Brussels, Belgium, 1090 |
| Belgium | Leuven, Belgium, 3000 |
| Germany, Baden-Württemberg | Heidelberg, Baden-Württemberg, Germany, 69120 |
| Germany, Baden-Württemberg | Tübingen, Baden-Württemberg, Germany, 72076 |
| Germany, Baden-Württemberg | Ulm, Baden-Württemberg, Germany, 89075 |
| Germany, Berlin | Berlin, Germany, 13353 |
| Germany, Rheinland-Pfalz | Mainz, Rheinland-Pfalz, Germany, 55131 |
| Germany, Sachsen | Dresden, Sachsen, Germany, 1307 |
| Germany, Schleswig-Holstein | Kiel, Schleswig-Holstein, Germany, 24105 |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2024 Pharma Intelligence UK Limited (Citeline), a Norstella company